Loading company details...
Beta
Latest Form 4 (Oct 13, 2026): Joseph M. Miller (Chief Financial Officer): Grant/Award of 200,000 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | Joseph M. Miller, Chief Financial Officer | Grant/Award | 200,000 | n/a |
| Oct 13, 2026 | Susan Gani Kozauer, Chief Medical Officer | Grant/Award | 200,000 | n/a |
| Aug 3, 2026 | Deep Track Biotechnology Master Fund, Ltd. | Purchase | 286,205 | $10.00M |
| Jun 5, 2026 | Robert R. Ruffolo | Grant/Award | 10,000 | n/a |
| Jun 5, 2026 | Ran Nussbaum | Grant/Award | 10,000 | n/a |
| Jun 5, 2026 | Rebecca Luse | Grant/Award | 10,000 | n/a |
| Jun 5, 2026 | Robert A. Lenz | Grant/Award | 12,500 | n/a |
| Jun 5, 2026 | Rekha Hemrajani | Grant/Award | 10,000 | n/a |
| Jun 5, 2026 | William P. Kane Jr. | Grant/Award | 10,000 | n/a |
| Jun 5, 2026 | J. Scott Garland | Grant/Award | 10,000 | n/a |